CU6 2.11% $6.97 clarity pharmaceuticals ltd

Ann: Positive topline results from SAR-bisPSMA diagnostic trial, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 114 Posts.
    lightbulb Created with Sketch. 23
    Great announcement and validation of Cu 64.
    i really like this comparison from the latest Wilsons Research report comparing of 68Ga PSMA-11 (left) to Clarity’s 64Cu SAR-bisPSMA (right) in the same patient. It is like looking at a fuzzy 1980's TV picture compared to a Ultra HD 4K picture. I know which Isotope I would want to use if I am the Oncologist. Bring on Phase 3.

    https://hotcopper.com.au/data/attachments/4912/4912015-faaba821bb2f0016557ec449ec22e411.jpg
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$6.97
Change
-0.150(2.11%)
Mkt cap ! $2.228B
Open High Low Value Volume
$7.01 $7.14 $6.76 $12.67M 1.830M

Buyers (Bids)

No. Vol. Price($)
4 27392 $6.91
 

Sellers (Offers)

Price($) Vol. No.
$6.99 1432 1
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.